← All stocks

Becton Dickinson

BDX Net selling
CIK 0000010795 #66 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$2.78M
$617.52K on a plan · $1.51M straight out of an exercise
Sold at will
$653.23K
3 of 22 sales
Net
−$2.78M
−$653.23K against sales at will

By person

29 insiders · 22 transactions
14.8×

Thomas E. Polen holds 14.8 times base salary in stock. $20.76M of shares against $1.40M in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas E. Polen last reported holding, valued at $188.49, the price Common Stock was last bought or sold at on the open market here, on 26 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Polen Thomas E Jr
Chairman, CEO and President
$1.17M (2) scheduled
−$1.17M
110,163
0.0404%
$20.76M
+44.0%
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
$784.16K (5) scheduled
−$784.16K
13,172
0.0048%
$2.48M
+52.1%
Goette Roland
EVP and President, EMEA
$440.89K (1)
−$440.89K
14,856
0.0055%
$2.80M
+17.4%
SCOTT BERTRAM L
Director
$212.35K (2)
−$212.35K
36,763
0.0135%
$6.93M
+0.4%
Feld Michael
EVP, Chief Revenue Officer
$167.36K (12) scheduled
−$167.36K
19,720
0.0072%
$3.72M
+70.2%
RING TIMOTHY M
Director
59,160
0.0217%
$11.15M
+3.5%
Muhsin Bilal
EVP & President Connected Care
41,359
0.0152%
$7.80M
+474.4%
Jones Christopher Ian Montague
Director
24,304
0.0089%
$4.58M
+9.1%
Neal Shana Carol
EVP and Chief People Officer
23,966
0.0088%
$4.52M
+19.3%
DelOrefice Christopher
EVP & Chief Financial Officer
22,982
0.0084%
$4.33M
+79.7%
Fraser Claire
Director
22,226
0.0082%
$4.19M
−3.7%
BURZIK CATHERINE M
Director
14,264
0.0052%
$2.69M
+7.0%
Menziuso Peter
EVP and President, BDI
14,258
0.0052%
$2.69M
Byrd Richard
EVP & President Interventional
13,849
0.0051%
$2.61M
+128.5%
Ezell Antoine C
EVP, President Americas & CMO
11,970
0.0044%
$2.26M
+28.4%
ECKERT R ANDREW
Director
10,423
0.0038%
$1.96M
+24.2%
Henderson Jeffrey William
Director
9,143
0.0034%
$1.72M
+62.8%
Shan David
EVP and Chief ISC Officer
8,926
0.0033%
$1.68M
+56.8%
Roque Vitor
EVP & Chief Financial Officer
8,041
0.0030%
$1.52M
+44.1%
Minnix Lanesha
EVP and General Counsel
7,492
0.0028%
$1.41M
HAYES GREGORY
Director
7,159
0.0026%
$1.35M
+47,627%
Quinn Michelle
EVP and General Counsel
6,927
0.0025%
$1.31M
+39.8%
Mocherla Pavan Kumar
EVP & President, Greater Asia
5,763
0.0021%
$1.09M
+218.0%
Byington Carrie L
Director
5,018
0.0018%
$945.84K
+67.8%
Brown William M
Director
4,663
0.0017%
$878.93K
+77.0%
Waldstreicher Joanne
Director
3,391
0.0012%
$639.17K
+148.8%
Spikner Pamela L.
SVP Controller & CAO
3,323
0.0012%
$626.35K
+167.6%
Huffines Robert Luther
Director
1,279
0.0005%
$241.08K
+127,800%
Wright Jacqueline
Director
1,279
0.0005%
$241.08K
+127,800%
Insider
Date
Role
Action
Shares
Price
Amount
Polen Thomas E Jr
13 Aug 2026
Chairman, CEO and President
Sold after exercise
4,152
$185.00
$768.12K
Polen Thomas E Jr
1 Jun 2026
Chairman, CEO and President
Sold after exercise
2,764
$146.35
$404.51K
Garrison Michael David
15 Jan 2026
EVP & Pres Med.Essntl&BioPharm
Sold after exercise
1,010
$206.54
$208.61K
Garrison Michael David
15 Jan 2026
EVP & Pres Med.Essntl&BioPharm
Sold after exercise
600
$209.00
$125.40K

What was left out

Form 4 filings counted 65
Amendments (4/A) skipped 0
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 4
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 298,834
History held since 7 Sep 2016